Updated:
Pharmakon Advisors
Pharmakon Advisors is an SEC-registered investment adviser in New York, NY, registered since 2012. The firm manages approximately $3.0 billion in regulatory...
Pharmakon Advisors
Pharmakon Advisors is an SEC-registered investment adviser in New York, NY, registered since 2012. The firm manages approximately $3.0 billion in regulatory assets. It has 15 employees and 9 investment advisers.
General information
Firm type
Asset Manager
Location
Region
North America
Country
United States
City
New York
Corporate office
110 East 59th Street #2800, New York, NY 10022, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Pharmakon Advisors?
Pharmakon Advisors does not publicly disclose the names of its investment committee or portfolio managers. The firm's website lists no individual principals. Institutional allocators conducting due diligence should request team bios directly.
What types of life sciences companies does Pharmakon target?
The firm invests across biotechnology, pharmaceuticals, medical technology, and diagnostics. It targets late-stage companies with approved products or near-commercial assets. This positions its loans as lower-risk within the biotech sector.
How large is Pharmakon's total deployment?
As of the firm's website, Pharmakon Advisors has committed over $11 billion across 74 transactions. This figure represents total capital committed, not AUM. Current AUM is not disclosed.
What is the BioPharma Credit Investment fund?
The BioPharma Credit Investment funds are the investment vehicles managed by Pharmakon Advisors. These funds provide structured debt financing to life sciences companies. They are structured as closed-end funds, offering long-dated capital.
Which sectors does Pharmakon explicitly avoid?
Pharmakon does not publicly state sectors it avoids. Based on its disclosed focus, it does not invest in early-stage biotech without products, nor in healthcare services or providers. Its mandate is limited to life sciences companies with commercial or near-commercial assets.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on registered investment advisers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: